Eilyn Lacy
5Patents
1h-index
15Co-inventors
40Inventor score
Filing activity: Nov 6, 2014 → Oct 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9944697B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10829549B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US11414484B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12234280B2 | Anti-PHF-tau antibodies and uses thereof | Physics | 0 | Active |
| US10633435B2 | Anti-PHF-tau antibodies and uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.